Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2019 Feb;85(2):377-384.
doi: 10.1111/bcp.13804. Epub 2018 Dec 3.

The role of vascular endothelium in nitroglycerin-mediated vasodilation

Affiliations
Randomized Controlled Trial

The role of vascular endothelium in nitroglycerin-mediated vasodilation

Kangbin Zhou et al. Br J Clin Pharmacol. 2019 Feb.

Abstract

Aims: Nitroglycerin (or glyceryl trinitrate, GTN) has been long considered an endothelium-independent vasodilator because GTN vasodilation is intact in the absence of the endothelium and in the presence of endothelial dysfunction. However, in animal and in vitro models, GTN has been shown to stimulate the release of certain endothelium-derived vasodilators such as nitric oxide (NO) and prostacyclin (PGI2 ). In addition, chronic GTN therapy leads to endothelial dysfunction. In this series of experiments, we explored how GTN might interact with the vascular endothelium in normal humans, without cardiovascular disease or risk factors associated with abnormalities in vascular function.

Methods: We examined the effect of inhibition of NO, PGI2 , and epoxyeicosatrienoic acids (EETs, a class of endothelium-derived hyperpolarizing factor) on GTN-mediated vasodilation. We measured arterial blood flow responses to brachial artery infusions of GTN in the absence and presence of L-NMMA (n = 13), ketorolac (n = 14) and fluconazole (n = 16), which are inhibitors of endothelium-derived NO, PGI2 and EETs, respectively, in healthy volunteers.

Results: Our results demonstrate that inhibition of endothelium-dependent vasodilator mechanisms does not alter forearm resistance vessel responses to GTN.

Conclusion: We conclude that GTN-mediated dilation of forearm resistance vessels is largely independent of vascular endothelium.

Keywords: cardiovascular pharmacology; endothelium; nitric oxide; pharmacokinetic-pharmacodynamic.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Summary of experimental procedures: the procedure timeline for all four experimental conditions GTN = glyceryl trinitrate (or nitroglycerin).
Figure 2
Figure 2
The effect of endothelium inhibition on GTN‐mediated vasodilation: forearm blood flow responses to intra‐arterial infusions of GTN in the absence and presence of endothelium inhibitor L‐NMMA, ketorolac, and fluconazole FBF = forearm blood flow; GTN = glyceryl trinitrate (or nitroglycerin)

Similar articles

Cited by

References

    1. Murrell W. Nitroglycerine as a remedy for angina pectoris. Lancet 1879; 1: 80–81.
    1. Münzel T, Daiber A, Gori T. Nitrate therapy: new aspects concerning molecular action and tolerance. Circulation 2011; 123: 2132–2144. - PubMed
    1. Münzel T, Gori T. Nitrate therapy and nitrate tolerance in patients with coronary artery disease. Curr Opin Pharmacol 2013; 13: 251–259. - PubMed
    1. Fung HL. Biochemical mechanism of nitroglycerin action and tolerance: is this old mystery solved? Annu Rev Pharmacol Toxicol 2004; 44: 67–85. - PubMed
    1. Abou‐Mohamed G, Kaesemeyer WH, Caldwell RB, Caldwell RW. Role of L‐arginine in the vascular actions and development of tolerance to nitroglycerin. Br J Pharmacol 2000; 130: 211–218. - PMC - PubMed

Publication types

MeSH terms

Grants and funding